| 000 | 01716 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515113108.0 | ||
| 264 | 0 | _c20080617 | |
| 008 | 200806s 0 0 eng d | ||
| 022 | _a1055-9965 | ||
| 024 | 7 |
_a10.1158/1055-9965.EPI-07-2929 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGwinn, Marta | |
| 245 | 0 | 0 |
_aIntention to analyze in pharmacogenomics studies. _h[electronic resource] |
| 260 |
_bCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology _cMar 2008 |
||
| 300 |
_a740; author reply 740-1 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 | _aAdministration, Cutaneous |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCatechol O-Methyltransferase _xgenetics |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNicotine _xadministration & dosage |
| 650 | 0 | 4 |
_aNicotinic Agonists _xadministration & dosage |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aSex Factors |
| 650 | 0 | 4 | _aSmoking Cessation |
| 650 | 0 | 4 |
_aTobacco Use Disorder _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aGuessous, Idris | |
| 700 | 1 | _aKhoury, Muin | |
| 773 | 0 |
_tCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology _gvol. 17 _gno. 3 _gp. 740; author reply 740-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1055-9965.EPI-07-2929 _zAvailable from publisher's website |
| 999 |
_c17850473 _d17850473 |
||